CANCERNET

Welcome to the Brand page for “CANCERNET”, which is offered here for Diagnostic biomarker reagents for medical purposes; diagnostic reagents for medicinal use; medical diagnostic reagents; medical diagnostic reagents for the analysis of body fluids; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, sepsis; medical diagnostic reagents and assays for testing body fluids for microorganisms; medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences and chemical reagents for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic purposes;assays for research purposes; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific use; diagnostic reagents for scientific or research use; reagents for research purposes; reagents for scientific or medical research use; assays and reagents for use in genetic research; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology;health care services, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical diagnostic testing, monitoring and reporting services; medical screening services in the field of cancer; medical testing for diagnostic or treatment purposes; genetic testing of animals for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals;biological research; biomedical research services; dna analysis services for scientific research purposes; laboratory research services relating to pharmaceuticals; laboratory research in the field of genetics; medical laboratory services; medical research services in the field of cancer; pharmaceutical research and development; product research and development; research and development of new products; research on the subject of pharmaceuticals; scientific laboratory services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; providing laboratory research services in the field of gene expression, cancer biology; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; research and development and consultation related thereto in the field of genetics; research and development of new products for others; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; research and development of technology in the field of genetics; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines;.

Its status is currently believed to be active. Its class is unavailable. “CANCERNET” is believed to be currently owned by “Cellecta, Inc”.